Related Experiment Video

Updated: Sep 17, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

[Clinical and molecular genetic studies of Machado-Joseph disease]

M Nishizawa1

  • 1Department of Neurology, Jichi Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 1, 1999
PubMed

Insights

Machado-Joseph disease (MJD), a common ataxia, shows unstable CAG repeats during inheritance. Paternal transmission and gene polymorphisms influence this instability, with sperm analysis revealing repeat contractions.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Context:

  • Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3, is the most prevalent autosomal dominant ataxia.
  • Understanding the genetic underpinnings of MJD is crucial for developing targeted therapies.

Purpose:

  • To review the clinical and molecular genetic aspects of Machado-Joseph disease.
  • To explore the instability of expanded CAG repeats in the MJD1 gene during parent-offspring transmission.

Summary:

  • Haplotype and MJD1 gene polymorphism analyses excluded founder chromosome presence in global MJD patients.
  • Expanded CAG repeat instability is influenced by paternal transmission and flanking polymorphisms.
  • Single sperm analysis revealed paradoxical CAG repeat contraction in MJD patients.

Impact:

  • Identifies key factors contributing to MJD genetic instability.
  • Provides insights into the relationship between CAG repeat size, anticipation, and clinical presentation.
  • Highlights the complexity of MJD inheritance patterns and molecular mechanisms.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Concept Videos

Sex-linked Disorders02:28

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.Y chromosome mutations are called “Y-linked” and only affect males since they alone carry a copy of that chromosome. Mutations to the relatively small Y chromosome can impact male sexual function and secondary sex characteristics. Y-chromosome infertility is a disorder that affects sperm...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...